Chi-Med begins Phase I trial of lymphoma drug in China

Hutchison China MediTech (Chi-Med) has begun a Phase I clinical trial of its therapeutic candidate HMPL-689 to treat patients with non-Hodgkin lymphoma in China.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news